Vascular Pharmaceuticals' Series A - II Round

Vascular Pharmaceuticals raised a round of funding on March 03, 2015.

Vascular Pharmaceuticals is a biopharmaceutical company developing VPI-2690B for complications of diabetes such as diabetic nephropathy. The company was formed based on research conducted at the Unive…

Articles about Vascular Pharmaceuticals' Series A - II Round: